This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2023 Sep 1;159(9):915-917.

doi: 10.1001/jamadermatol.2023.2608.

Can Serum Biomarkers for Prurigo Nodularis Expose Pathophysiology or Just Treatment Response?

Sakeen W Kashem^{1

2}, Marlys S Fassett^{1

3}

Affiliations

Affiliations

¹ Department of Dermatology, University of California, San Francisco.
² Department of Anatomy, University of California, San Francisco.
³ Department of Microbiology and Immunology, University of California, San Francisco.

PMID: 37556170
DOI: 10.1001/jamadermatol.2023.2608

Comment

Can Serum Biomarkers for Prurigo Nodularis Expose Pathophysiology or Just Treatment Response?

Sakeen W Kashem et al. JAMA Dermatol. 2023.

. 2023 Sep 1;159(9):915-917.

doi: 10.1001/jamadermatol.2023.2608.

Authors

Sakeen W Kashem^{1

2}, Marlys S Fassett^{1

3}

Affiliations

¹ Department of Dermatology, University of California, San Francisco.
² Department of Anatomy, University of California, San Francisco.
³ Department of Microbiology and Immunology, University of California, San Francisco.

PMID: 37556170
DOI: 10.1001/jamadermatol.2023.2608

No abstract available

PubMed Disclaimer

Comment on

Modulation of Neuroimmune and Epithelial Dysregulation in Patients With Moderate to Severe Prurigo Nodularis Treated With Nemolizumab.
Deng J, Liao V, Parthasarathy V, Cornman HL, Kambala A, Kwatra MM, Ständer S, Piketty C, Chaskar P, Krishnaswamy JK, Julia V, Kwatra SG. Deng J, et al. JAMA Dermatol. 2023 Sep 1;159(9):977-985. doi: 10.1001/jamadermatol.2023.2609. JAMA Dermatol. 2023. PMID: 37556125 Free PMC article.

Publication types

Actions

MeSH terms

Actions
Actions
Actions

Substances

Actions

Grants and funding

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems